Clinical Trial Update: Hybrid APC Therapy in Early Central Lung Neoplasms [NA]

View source ↗

Summary

The document reports that a Hybrid APC Therapy trial for early central lung neoplasms has completed. No results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Hybrid APC Therapy

Snippet

Sponsor: Jiayuan Sun | Conditions: Lung Neoplasms | NA | Status: COMPLETED